Description: Evolva is a 10-year old venture, committed to doing what we can to help people around the world improve their health, wellness and nutrition in sustainable way. We employ some 150 people in Europe, North America and Asia, offering all of them equity participation in our company. We are not going to get everything right, but we believe that by creatively combining new things, evolving and adapting, in both our science and in our culture, we aim to play a modest role in helping solve some of the big issues of today.
Home Page: www.evolva.com
Duggingerstrasse 23
Reinach,
4153
Switzerland
Phone:
41 61 485 2000
Officers
| Name | Title |
|---|---|
| Mr. Gerhard Lobmaier | Chief Operations Officer |
| Thomas Schneckenburger C.F.A., Ph.D. | Head of Investor & Corporate Relations |
| Philipp Frech | General Counsel & Secretary of the Board |
| Ms. Anne De Vos | Head of Sales |
| Ms. Astrid Schafer | Head of Innovation |
| Dr. Luc Gruner | Executive Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8091 |
| Price-to-Sales TTM: | 1.7624 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |